NCT06011486View on ClinicalTrials.gov

Expansion of Virus-Specific Lymphocytes for Cell Therapy

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

June 10, 2025

Study Completion Date

June 10, 2026

Conditions
CMV ViremiaCMV
Interventions
COMBINATION_PRODUCT

Lymphocyte infusion (ImmuneCellVir-I)

Infusion of donor CMV specific cells into patients eligible to the trial

Trial Locations (1)

05653000

RECRUITING

Hospital Israelita Albert Einstein, São Paulo

All Listed Sponsors
lead

Hospital Israelita Albert Einstein

OTHER